Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
An initial 4-8 week assessment period allows evaluation of individual response and tolerance before committing to extended therapy
They take five minutes, dont hurt (promise), and can make a huge difference in how you feel day to day
Clinical Trials Multicenter, randomized controlled trial: To verify the efficacy and safety of AOD 9604 in humans
In addition, recent economic trends have shown an increase in demand for natural, non-invasive treatments like B-12 injections
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
